Lazard Asset Management LLC Amgen Inc Transaction History

Lazard Asset Management LLC

$61.8 Billion
Q4 2024

A detailed history of Lazard Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 6,502 shares of AMGN stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,502

Previous 11,350 42.71%

Holding current value

$1.89 Million

Previous $3.66 Million 53.68%

% of portfolio

0.0%

Previous 0.01%

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $1.25 Million - $1.59 Million	-4,848 Reduced 42.71%	6,502 $1.69 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $2.94 Million - $3.21 Million	-9,512 Reduced 45.59%	11,350 $3.66 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $2.88 Million - $3.51 Million	-10,979 Reduced 34.48%	20,862 $6.52 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $363,781 - $439,129	1,353 Added 4.44%	31,841 $9.05 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $1.56 Million - $1.76 Million	-6,107 Reduced 16.69%	30,488 $8.78 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $4.27 Million - $5.3 Million	19,532 Added 114.47%	36,595 $9.84 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $409,255 - $483,936	1,910 Added 12.6%	17,063 $3.79 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $2.16 Million - $2.64 Million	-9,587 Reduced 38.75%	15,153 $3.66 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $243,458 - $309,343	-1,063 Reduced 4.12%	24,740 $6.5 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $3.36 Million - $3.79 Million	-14,962 Reduced 36.7%	25,803 $5.81 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $7.88 Million - $8.77 Million	-34,158 Reduced 45.59%	40,765 $9.92 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $4.42 Million - $4.89 Million	-20,147 Reduced 21.19%	74,923 $18.1 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $1.41 Million - $1.61 Million	7,072 Added 8.04%	95,070 $21.4 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $39,694 - $46,506	-187 Reduced 0.21%	87,998 $18.7 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $158,834 - $176,215	-680 Reduced 0.77%	88,185 $21.5 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $15.2 Million - $17.7 Million	68,534 Added 337.09%	88,865 $22.1 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $419,344 - $499,364	-1,938 Reduced 8.7%	20,331 $4.67 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $48.9 Million - $54.4 Million	-208,286 Reduced 90.34%	22,269 $5.66 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $9.2 Million - $11.3 Million	-46,486 Reduced 16.78%	230,555 $54.4 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $3.04 Million - $4.03 Million	-16,689 Reduced 5.68%	277,041 $56.2 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $855,039 - $1.1 Million	4,519 Added 1.56%	293,730 $70.8 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $20.1 Million - $24.1 Million	115,666 Added 66.65%	289,211 $56 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $19.1 Million - $22.4 Million	-114,854 Reduced 39.82%	173,545 $32 Million
Q1 2019 Aug 28, 2019	SELL	$180.87 - $203.88 $9,947 - $11,213	-55 Reduced 0.02%	288,399 $54.8 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $12 Million - $13.5 Million	66,209 Added 29.79%	288,454 $54.8 Million
Q4 2018 Aug 28, 2019	BUY	$178.4 - $208.25 $20,872 - $24,365	117 Added 0.05%	222,245 $43.3 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $5.19 Million - $6.06 Million	29,109 Added 15.08%	222,128 $43.2 Million
Q3 2018 Aug 30, 2019	BUY	$185.29 - $208.89 $13,896 - $15,666	75 Added 0.04%	193,019 $40 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $6.03 Million - $6.8 Million	32,535 Added 20.28%	192,944 $40 Million
Q2 2018 Aug 30, 2019	BUY	$166.05 - $186.51 $12,453 - $13,988	75 Added 0.05%	160,409 $29.6 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $3.89 Million - $4.37 Million	23,434 Added 17.12%	160,334 $29.6 Million
Q1 2018 Aug 28, 2019	BUY	$169.43 - $198.0 $12,707 - $14,850	75 Added 0.05%	136,900 $23.3 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $10.2 Million - $11.9 Million	60,308 Added 78.82%	136,825 $23.3 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $9.1 Million - $10.2 Million	-53,933 Reduced 41.34%	76,517 $13.3 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $152,735 - $174,383	-913 Reduced 0.7%	130,450 $24.3 Million
Q2 2017 Aug 19, 2019	SELL	N/A	-77,496 Reduced 37.1%	131,363 $22.6 Million
Q1 2017 Aug 13, 2019	SELL	N/A	-16,657 Reduced 7.39%	208,859 $34.3 Million
Q4 2016 Jul 30, 2019	BUY	N/A	60,808 Added 36.92%	225,516 $33 Million
Q3 2016 Aug 07, 2019	SELL	N/A	-23,096 Reduced 12.3%	164,708 $27.5 Million
Q2 2016 Jul 29, 2019	SELL	N/A	-99,624 Reduced 34.66%	187,804 $28.6 Million
Q1 2016 Jul 25, 2019	BUY	N/A	30,313 Added 11.79%	287,428 $43.1 Million
Q4 2015 Jul 24, 2019	BUY	N/A	63,191 Added 32.59%	257,115 $41.7 Million
Q3 2015 Jul 15, 2019	SELL	N/A	-1,214,698 Reduced 86.23%	193,924 $26.8 Million
Q2 2015 Jul 08, 2019	SELL	N/A	-564,451 Reduced 28.61%	1,408,622 $216 Million
Q4 2014 Aug 29, 2019	BUY	N/A	1,973,073	1,973,073 $314 Million

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Amgen Inc Transaction History